BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• Drug Development

  Receptos Initiates SUNBEAM Phase 3 Trial Of RPC1063 In Relapsing Multiple Sclerosis

  December 22, 2014

   · 

  6 min read
• BioMidwest

  Parnell Pharmaceuticals Holdings Management Adopts 10b5-1 Trading Plans

  December 22, 2014

   · 

  3 min read
• Drug Development

  FDA Grants Orphan Drug Designation To Nuvilex For Pancreatic Cancer Treatment

  December 22, 2014

   · 

  4 min read
• Biotech Bay

  Dermira Added To Russell 2000® Index

  December 22, 2014

   · 

  1 min read
• Business

  Apricus Biosciences Announces Year-End 2014 Update And 2015 Plans To Advance Its Clinical Pipeline And Further Commercialize Its Erectile Dysfunction Drug Vitaros®

  December 22, 2014

   · 

  13 min read
• Pharm Country

  Amicus Therapeutics, Inc. Added To NASDAQ Biotechnology Index (NBI)

  December 22, 2014

   · 

  1 min read
• Actavis Release: XYDALBA™ (dalbavancin) Receives CHMP Positive Opinion For The Treatment Of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) In Adults

  December 22, 2014

   · 

  3 min read
• Drug Development

  New Published Data Show Pluristem Therapeutics’s PLX Cells Protect Neurons

  December 22, 2014

   · 

  5 min read
• Concord Medical Services Holdings Limited To Hold Annual General Meeting On January 27, 2015

  December 22, 2014

   · 

  2 min read
• Drug Development

  Synthetic Biologics, Inc. Announces Positive Topline Results From Phase 1a Trial Of SYN-004 For The Prevention Of C. Difficile Infection

  December 22, 2014

   · 

  6 min read